Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eone Diagnomics Genome Center
Incheon, South Korea
- Ownership
- Private
- Employees
- ~62
- Development stage
- Other
01
Overview
EDGC is a commercial genomics diagnostics company offering next generation sequencing-based tests and liquid biopsy assays for prenatal screening, hereditary cancers, disease risk prediction, and other clinical and consumer genetic applications, with products such as NICE NIPT, bebegene Plus newborn screening, hereditary cancer panels (RiskCARE, BRCARE), prediction tests (genocube, gene2me Plus), and liquid biopsy for cancer management.[1][3][4][8]
- Therapeutic areas
- OtherWomen's HealthRare DiseasesOncologyOphthalmology
- Modalities
- Diagnostic testDevice
- Industry
- Molecular Diagnostics
02
Partnerships
Illumina[1]Microsoft[1]
Beyond the preview
Go deeper on Eone Diagnomics Genome Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eone Diagnomics Genome Center.